Tommy S. de Windt

Tommy S. de Windt

Auto-generated profile, based on publicly available information

Tommy S. de Windt

Orthopedisch Centrum Oost Nederland Orthopedic Center Hengelo the Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2017 in Stem Cells
Verified
Journal Article
Open access
PDF file
TWTommy S. de Windt
Tommy S. de Windt
Lucienne VonkLucienne Vonk
Lucienne Vonk
ISIneke C. M. Slaper-Cortenbach
Ineke C. M. Slaper-Cortenbach
RNRazmara Nizak
Razmara Nizak
MRMattie H. P. van Rijen
Mattie H. P. van Rijen
DSDaniel B. F. Saris
Daniel B. F. Saris
MSCs are known as multipotent mesenchymal stem cells that have been found capable of differentiating into various lineages including cartilage. However, recent studies suggest MSCs are pericytes that stimulate tissue repair through trophic signaling. Aimed at articular cartilage repair in a one-stage cell transplantation, this study provides first clinical evidence that MSCs stimulate autologous cartilage repair in the knee without engrafting in the host tissue. A phase I (first-in-man) clinical trial studied the one-stage application of allogeneic MSCs mixed with 10% or 20% recycled defect derived autologous chondrons for the treatment of cartilage defects in 35 patients. No treatment-related serious adverse events were found and statistically significant improvement in clinical outcome shown. Magnetic resonance imaging and second-look arthroscopies showed consistent newly formed cartilage tissue. A biopsy taken from the center of the repair tissue was found to have hyaline-like features with a high concentration of proteoglycans and type II collagen. DNA short tandem repeat analysis delivered unique proof that the regenerated tissue contained patient-DNA only. These findings support the hypothesis that allogeneic MSCs stimulate a regenerative host response. This first-in-man trial supports a paradigm shift in which MSCs are applied as augmentations or “signaling cells” rather than differentiating stem cells and opens doors for other applications.

11 July 2017 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
TWTommy S. de Windt
Tommy S. de Windt
Lucienne VonkLucienne Vonk
Lucienne Vonk
DSDaniel B.F. Saris
Daniel B.F. Saris

24 July 2025 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Open access
Massimo InnocentiMassimo Innocenti
Massimo Innocenti
FLFilippo Leggieri
Filippo Leggieri
SLS.N. Van Laarhoven
S.N. Van Laarhoven
TWTommy de Windt
Tommy de Windt
RCRoberto Civinini
Roberto Civinini
GHGijs G. Van Hellemondt
Gijs G. Van Hellemondt
Purpose: The aim of this systematic review was to evaluate the outcomes and complications associated with technology‐assisted revision total knee arthroplasty (revTKA).Methods: A systematic search of PubMed, EMBASE, Web of Science and the Cochrane Library was conducted from inception to 31 October 2024. The inclusion criteria were experimental or observational studies with ≥10 patients undergoing robotic revTKA, evaluating clinical and/or radiological outcomes and/or complication rates. The exclusion criteria were isolated patellar revision, in vitro studies, letters to the editor, book chapters, conference papers, and studies without accessible full text. Each study was given a quality rating using the methodological index for non‐randomised studies (MINORS). The included studies were divided into those reporting revision from TKA and those from unicompartmental knee arthroplasty (UKA), for both qualitative and quantitative synthesis. Random‐effects meta‐analyses were performed where appropriate. Mean differences with 95% confidence intervals (CIs) were calculated for radiographic parameters. Heterogeneity was assessed using the I2 statistic.Results: Across 20 studies (795 cases), 10 assessed revTKA and 10 examined revUKA. Of the revTKA studies, four were comparative cohorts, while among the revUKA studies, seven were comparative cohorts. Technology‐assisted revTKA showed fewer outliers in hip–knee–ankle angle (13.3% [95% CI, 8.7%–19.0%] vs. 26.1% [95% CI, 16.3%–38.1%]), superior component positioning within ±3° for the lateral distal femoral angle (88.4% [95% CI, 83.2%–92.4%] vs. 79.7% [95% CI, 68.8%–87.5%]) and for the medial proximal tibial angle (91.2% [95% CI, 86.3%–94.6%] vs. 82.6% [95% CI, 72.0%–89.8%]), and better joint line restoration (79.5% vs. 58.3% within 4 mm). Procedures required an additional 15–24 min. Complication rates were comparable between groups. For UKA revisions, outcomes were generally similar between technology‐assisted and conventional techniques, with mixed results on alignment accuracy and clinical scores.Conclusion: Technology‐assisted revTKA achieves optimal alignment parameters and reduces the occurrence of outliers compared with conventional techniques. However, these radiographic improvements do not consistently translate into enhanced clinical outcomes or reduced complication rates.Level of Evidence: Level IV.

16 October 2017 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
DSDaniel B. F. Saris
Daniel B. F. Saris
TWTommy S. de Windt
Tommy S. de Windt
LVLucienne A. Vonk
Lucienne A. Vonk
AKAaron J. Krych
Aaron J. Krych
ATAndre Terzic
Andre Terzic